Cargando…

Towards Stratified Medicine in Plasma Cell Myeloma

Plasma cell myeloma is a clinically heterogeneous malignancy accounting for approximately one to 2% of newly diagnosed cases of cancer worldwide. Treatment options, in addition to long-established cytotoxic drugs, include autologous stem cell transplant, immune modulators, proteasome inhibitors and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egan, Philip, Drain, Stephen, Conway, Caroline, Bjourson, Anthony J., Alexander, H. Denis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085784/ https://www.ncbi.nlm.nih.gov/pubmed/27775669 http://dx.doi.org/10.3390/ijms17101760

Ejemplares similares

CD169+ Monocyte and Regulatory T Cell Subsets Are Associated with Disease Activity in Rheumatoid Arthritis
por: Eakin, Amanda J., et al.
Publicado: (2022)

Multiple myeloma with central nervous system relapse
por: Egan, Philip A., et al.
Publicado: (2020)

Defining resistance and tolerance traits in Covid-19: towards a stratified medicine approach
por: Russell, C D, et al.
Publicado: (2022)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
por: Davies, Faith E., et al.
Publicado: (2022)

Aligning the Economic Value of Companion Diagnostics and Stratified Medicines
por: Blair, Edward D., et al.
Publicado: (2012)

Myeloma therapy: pursuing the plasma cell
por: Cavenagh, J
Publicado: (2010)

Stratified Medicine and Reimbursement Issues
por: Fugel, Hans-Joerg, et al.
Publicado: (2012)

Beyond Genetics—Stratified and Personalised Medicines Using Multiple Parameters
por: Peck, Richard, et al.
Publicado: (2010)

Innovation Management? Orienting Sepsis R&D and Technology Transfer Towards Stratified Medicine
por: Özdemir, Vural, et al.
Publicado: (2016)

Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases
por: La Cognata, Valentina, et al.
Publicado: (2021)

Self-Knowledge and Risk in Stratified Medicine
por: Hordern, Joshua
Publicado: (2017)

Service users’ and carers’ views on research towards stratified medicine in psychiatry: a qualitative study
por: Rose, Diana, et al.
Publicado: (2015)

Artificial Intelligence in Plasma Cell Myeloma: Neural Networks and Support Vector Machines in the Classification of Plasma Cell Myeloma Data at Diagnosis
por: Yenamandra, Ashwini K., et al.
Publicado: (2021)

Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers
por: Malottki, Kinga, et al.
Publicado: (2014)

Extracellular crystals in plasma cell myeloma
por: Brown, Jacqueline T., et al.
Publicado: (2014)

Combining multiple predictive markers in stratified medicine
por: Emsley, Richard, et al.
Publicado: (2015)

Stratified medicine in rheumatoid arthritis—the MATURA programme
por: Barton, Anne, et al.
Publicado: (2017)

Scalability of self-stratifying microbial fuel cell: Towards height miniaturisation
por: Walter, Xavier Alexis, et al.
Publicado: (2019)

Targeting Multiple Myeloma through the Biology of Long-Lived Plasma Cells
por: Utley, Adam, et al.
Publicado: (2020)

Moving Toward Continuous Therapy in Multiple Myeloma
por: Bonello, Francesca, et al.
Publicado: (2019)

Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine
por: Simeon, Vittorio, et al.
Publicado: (2015)

Giant multinucleated plasma cells in relapsed plasma cell myeloma
por: Ghattas, Sylvia, et al.
Publicado: (2020)

Plasma Cell Myeloma Masquerading as Scleromyxedema
por: Victor, Varun, et al.
Publicado: (2019)

The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma
por: Giannakoulas, Nikolaos, et al.
Publicado: (2021)

Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring “Multiple Myelomas”
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

Economic Evaluation in Stratified Medicine: Methodological Issues and Challenges
por: Fugel, Hans-Joerg, et al.
Publicado: (2016)

Contested futures: envisioning “Personalized,” “Stratified,” and “Precision” medicine
por: Erikainen, Sonja, et al.
Publicado: (2019)

Prakriti phenotypes as a stratifier of gut microbiome: A new frontier in personalized medicine?
por: Jnana, Apoorva, et al.
Publicado: (2020)

The Genetic Architecture of Multiple Myeloma
por: Prideaux, Steven M., et al.
Publicado: (2014)

Stratified Management for Bacterial Infections in Late Preterm and Term Neonates: Current Strategies and Future Opportunities Toward Precision Medicine
por: Keij, Fleur M., et al.
Publicado: (2021)

A stratified therapeutic model incorporated with studies on regulatory B cells for elderly patients with newly diagnosed multiple myeloma
por: Tang, Wenjiao, et al.
Publicado: (2022)

The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology
por: Fan, Fengjuan, et al.
Publicado: (2021)

Phenotypic consensus markers for plasma cell myeloma
por: Hur, Mina
Publicado: (2012)

Toothache as the initial symptom of plasma cell myeloma
por: Wehrhahn, Tobias, et al.
Publicado: (2018)

Plasmablastic myeloma progressed to plasma cell leukaemia
por: Xu, Ke, et al.
Publicado: (2021)

Multifocal Extramedullary Plasma Cell Myeloma of the Colon
por: Karime, Christian, et al.
Publicado: (2023)

Using information of relatives in genomic prediction to apply effective stratified medicine
por: Lee, S. Hong, et al.
Publicado: (2017)

Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease
por: Lynch, Seodhna M., et al.
Publicado: (2021)

The Need for Standardizing Diagnosis, Treatment and Clinical Care of Cholecystitis and Biliary Colic in Gallbladder Disease
por: Doherty, Gerard, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l8l7lest9e7pr7g72kkb9a5nbm